Cargando…
Treatment of neuroendocrine carcinoma of the cervix with a PARP inhibitor based on next generation sequencing()
• This case reports the treatment of neuroendocrine carcinoma of the cervix with a PARPi based on NGS. • NGS reports have demonstrated somatic mutations BRCA in neuroendocrine carcinoma of the cervix. • The use of a PARPi in neuroendocrine carcinoma of the cervix has not been previously reported....
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804835/ https://www.ncbi.nlm.nih.gov/pubmed/31649992 http://dx.doi.org/10.1016/j.gore.2019.100499 |